Fig. 3.
Inhibition of tyrosine phosphorylation by SGX393 in primary Bcr-AblT315I cells. Bcr-AblT315I CML lymphoid blast crisis (CML L-BC) mononuclear cells incubated with SGX393, imatinib, dasatinib, or nilotinib overnight were subjected to immunoblot analysis with a total CrkL-specific antibody (Upper), and the ratio of phosphorylated CrkL to nonphosphorylated CrkL was determined by densitometry (Lower).